Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

被引：0
|
作者：
Christian Zurth
Mikko Koskinen
Robert Fricke
Olaf Prien
Timo Korjamo
Kristina Graudenz
Karsten Denner
Michaela Bairlein
Clemens-Jeremias von Bühler
Gary Wilkinson
Hille Gieschen
机构：
[1] Bayer AG,
[2] Orion Corporation,undefined
[3] Orion Pharma,undefined
[4] Bayer AG,undefined
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2019年 / 44卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 759
页数：12
相关论文
共 50 条
  • [21] Drug-Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model-Based Studies
    Merali, Samira
    Sychterz, Caroline
    Perera, Vidya
    Gaohua, Lu
    Florea, Victoria
    Murthy, Bindu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [22] Innovative Approaches to Optimize Clinical Transporter Drug-Drug Interaction Studies
    Paglialunga, Sabina
    Benrimoh, Natacha
    van Haarst, Aernout
    PHARMACEUTICS, 2024, 16 (08)
  • [23] IN VITRO ASSESSMENT OF DRUG-DRUG INTERACTION POTENTIAL OF BOCEPREVIR AS AN INHIBITOR AND INDUCER OF DRUG METABOLIZING ENZYMES AND TRANSPORTERS
    Chu, Xiaoyan
    Cai, Xiaoxin
    Cui, Dan
    Evers, Raymond
    Green, Mitchell D.
    Ghosal, Anima
    Tang, Cuyue
    Kuo, Yuhsin
    Liang, Yuexia
    Maciolek, Cheri M.
    Palamanda, Jairam
    Yabut, Jocelyn
    Prueksaritanont, Thomayant
    HEPATOLOGY, 2011, 54 : 547A - 547A
  • [24] An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction
    Reese, Melinda J.
    Wurm, Robert M.
    Muir, Keith T.
    Generaux, Grant T.
    St John-Williams, Lisa
    McConn, Donavon J.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) : 1198 - 1201
  • [25] In vitro metabolism of indiplon and an assessment of its drug interaction potential
    Madan, A.
    Fisher, A.
    Jin, L.
    Chapman, D.
    Bozigian, H. P.
    XENOBIOTICA, 2007, 37 (07) : 736 - 752
  • [26] In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine
    Joshi, Anand
    Kiesel, Brian F.
    Chaphekar, Nupur
    Jones, Reyna
    Guo, Jianxia
    Kunos, Charles A.
    Taylor, Sarah
    Chu, Edward
    Venkataramanan, Raman
    Beumer, Jan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (05) : 633 - 640
  • [27] Limitations of In Vitro Assessments of the Drug Interaction Potential of Botanical Supplements
    Markowitz, John S.
    Zhu, Hao-Jie
    PLANTA MEDICA, 2012, 78 (13) : 1421 - 1427
  • [28] In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine
    Anand Joshi
    Brian F. Kiesel
    Nupur Chaphekar
    Reyna Jones
    Jianxia Guo
    Charles A. Kunos
    Sarah Taylor
    Edward Chu
    Raman Venkataramanan
    Jan H. Beumer
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 633 - 640
  • [29] Limitations of in vitro assessments of the drug interaction potential of botanical supplements
    Markowitz, J. S.
    PLANTA MEDICA, 2015, 81 (16) : 1395 - 1395
  • [30] IN VITRO DRUG INTERACTION STUDIES OF UNI-494 INDICATE LOW RISK OF DRUG-DRUG INTERACTIONS
    Reddy, Guru
    Gupta, Pramod
    Khare, Atul
    Gupta, Shalabh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S8 - S8
12345